









Markets
/
Stocks
/
nasdaq-mrus
/

Merus NV

MRUS

View Detailed Chart

65.560USD

-0.680-1.03%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

4.54BMarket Cap

LossP/E TTM



Merus NV

65.560

-0.680-1.03%

Overview Company Financials

Financials

Intraday

30m

Today

-1.03%

5 Days

-1.89%

1 Month

+21.81%

6 Months

+65.51%

Year to Date

+55.91%

1 Year

+25.83%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 18 analysts

BUY

Current Rating

91.250

Target Price

39.19%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Merus NV

MRUS

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(3)

Neutral(2)

Buy(6)

Indicators

Sell(2)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.604

Buy

RSI(14)

69.606

Neutral

STOCH(KDJ)(9,3,3)

74.080

Sell

ATR(14)

2.384

High Vlolatility

CCI(14)

60.436

Neutral

Williams %R

15.037

Overbought

TRIX(12,20)

0.953

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

65.894

Sell

MA10

65.176

Buy

MA20

60.630

Buy

MA50

56.467

Buy

MA100

49.866

Buy

MA200

47.559

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.

Ticker SymbolMRUS

CompanyMerus NV

CEODr. Sven Ante (Bill) Lundberg, M.D.

Websitehttps://merus.nl/